Home » Topics » Regulatory

Regulatory
RSS

FDA approves Isentress pediatric oral suspension

Jan. 10, 2014

FDA approves Orenitram for PAH

Dec. 24, 2013

FDA approves Sovaldi for chronic hepatitis C

Dec. 9, 2013

FDA approves Xiaflex for Peyronie's disease

Dec. 9, 2013

Daiichi Sankyo launches new formulation of natural tetrahydrobiopterin agent

Dec. 2, 2013

FDA approves Varithena for the treatment of patients with incompetent veins

Nov. 28, 2013

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

FDA approves Nexavar for thyroid cancer

Nov. 25, 2013

Onoact 50 approved in Japan for new indication

Nov. 22, 2013

European approval of Kineret for CAPS

Nov. 21, 2013

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...